quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:30:00·37d
PRRelease
BriaCell Therapeutics Corp. logo

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

BCTX· BriaCell Therapeutics Corp.
Health Care
Original source

Companies

  • BCTX
    BriaCell Therapeutics Corp.
    Health Care

Recent analyst ratings

  • Feb 14UpdateHC Wainwright & Co.$25.00

Related

  • PR3d
    BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models
  • PR4d
    BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting
  • SEC23d
    BriaCell Therapeutics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR23d
    BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
  • SEC44d
    SEC Form 10-Q filed by BriaCell Therapeutics Corp.
  • PR45d
    BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
  • SEC45d
    BriaCell Therapeutics Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
  • PR49d
    BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022